(Q37969996)

26 August 2017

title

Infectious complications in dialysis--epidemiology and outcomes (English)

1 reference

26 August 2017

0 references

1 reference

1

Philip Kam-Tao Li

0 references

author name string

Kai Ming Chow

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

20 December 2011

1 reference

Nature Reviews Nephrology

26 August 2017

published in

1 reference

26 August 2017

volume

8

1 reference

26 August 2017

issue

2

1 reference

26 August 2017

page(s)

77-88

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2011.194

26 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Septicemia in dialysis patients: incidence, risk factors, and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Epidemiology of acute infections among patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Severe bloodstream infections: a population-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Clinical practice guidelines for vascular access.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Description of a new surveillance system for bloodstream and vascular access infections in outpatient hemodialysis centers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Prevention and management of catheter-related infection in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

A prospective study of vascular access infections at seven outpatient hemodialysis centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Surveillance of hemodialysis-associated primary bloodstream infections: the experience of ten hospital-based centers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Surveillance of chronic haemodialysis-associated infections in southern Israel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Staphylococcus aureus infections in hemodialysis: what a nephrologist should know.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Clinical outcome and costs of nosocomial and community-acquired Staphylococcus aureus bloodstream infection in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Nasal carriage of methicillin-resistant Staphylococcus aureus is associated with higher all-cause mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Recent changes in vancomycin use in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Rapid curbing of a vancomycin-resistant Enterococcus faecium outbreak in a nephrology department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Prevention of catheter-related bloodstream infection in patients on hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Emergence of gentamicin-resistant bacteremia in hemodialysis patients receiving gentamicin lock catheter prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Differing outcomes of gram-positive and gram-negative peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Peritoneal dialysis catheter removal for acute peritonitis: a retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Pseudomonas peritonitis in Australia: predictors, treatment, and outcomes in 191 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Patient to patient transmission of hepatitis B virus: a systematic review of reports on outbreaks between 1992 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Review article: Hepatitis B and dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Extra-high-dose hepatitis B vaccination does not confer longer serological protection in peritoneal dialysis patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Seroconversion rate to positivity for antibodies against core antigen of hepatitis B virus and duration of renal replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Determinant roles of environmental contamination and noncompliance with standard precautions in the risk of hepatitis C virus transmission in a hemodialysis unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Holiday haemodialysis and imported hepatitis C virus infection: a series of sixteen cases in two large haemodialysis units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

National surveillance of dialysis-associated diseases in the United States, 1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

National surveillance of dialysis-associated diseases in the United States, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Increasing home based dialysis therapies to tackle dialysis burden around the world: a position statement on dialysis economics from the 2nd Congress of the International Society for Hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Pulmonary infectious mortality among patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Pneumonia in incident dialysis patients--the United States Renal Data System

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Severe acute respiratory syndrome in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Septicemia in the United States dialysis population, 1991 to 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Prospective Surveillance for Primary Bloodstream Infections Occurring in Canadian Hemodialysis Units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Vascular access-related bloodstream infections in First Nations, community and teaching Canadian dialysis units, and other centre-level predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Complications associated with the development of bacteremia with Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Interventions for preventing infectious complications in haemodialysis patients with central venous catheters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

PERITONEAL DIALYSIS-RELATED INFECTIONS RECOMMENDATIONS: 2010 UPDATE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Pseudomonas peritonitis in peritoneal dialysis patients: the Network #9 Peritonitis Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: the DOPPS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Hepatitis B virus infection in hemodialysis populations: progress toward prevention

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Influenza vaccine delivery and effectiveness in end-stage renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.194

Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008.

31 March 2020

1 reference

12 December 2020

Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

1 reference

12 December 2020

EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.

1 reference

12 December 2020

ISPD position statement on reducing the risks of peritoneal dialysis-related infections

1 reference

12 December 2020

Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission

1 reference

12 December 2020

Antibiotic lock solutions for the prevention of catheter-related bacteraemia in haemodialysis patients

1 reference

12 December 2020

Gram-negative peritonitis--the Achilles heel of peritoneal dialysis?

1 reference

12 December 2020

Mortality caused by sepsis in patients with end-stage renal disease compared with the general population.

1 reference

12 December 2020

Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update

1 reference

12 December 2020

Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients.

1 reference

12 December 2020

Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases

1 reference

12 December 2020

'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States.

1 reference

12 December 2020

KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease.

1 reference

12 December 2020

Recommendations for preventing transmission of infections among chronic hemodialysis patients

1 reference

12 December 2020

Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing

1 reference

12 December 2020

Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis

1 reference

12 December 2020

Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update.

1 reference

12 December 2020

Peritoneal dialysis-related infections recommendations: 2005 update.

1 reference

12 December 2020

The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients

1 reference

12 December 2020

Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2011.194

1 reference

26 August 2017

1 reference